Conservative management of cervical intraepithelial neoplasia 2 and prediction of its progression - a retrospective study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cervical intraepithelial neoplasia 2 (CIN2) can progress or persist, especially with high-risk HPV genotypes and abnormal cytology. Careful monitoring is crucial for patients with HSIL or ASC-H cytology, with or without high-risk HPV strains, to manage CIN2 progression risk.
Area Of Science
- Gynecology
- Oncology
- Virology
Background
- Cervical intraepithelial neoplasia 2 (CIN2) behavior is debated, with some cases spontaneously regressing.
- Understanding CIN2 progression and persistence is vital for effective patient management and treatment strategies.
Purpose Of The Study
- To determine the rate of CIN2 progression or persistence over a 24-month follow-up period.
- To identify clinical predictors, including human papillomavirus (HPV) genotype and cytology results, associated with CIN2 outcomes.
Main Methods
- A retrospective case-control study involving reproductive-age patients diagnosed with CIN2.
- Patients were categorized into regression (n=72) or progression/persistence (n=36) groups.
- Multinomial logistic regression and linear regression analyses were used to assess risk factors and interactions.
Main Results
- Previous high-grade squamous intraepithelial lesion (HSIL) or atypical squamous cells, cannot exclude HSIL (ASC-H) cytology significantly increased CIN2 progression/persistence risk (RRR: 3.85).
- Presence of HPV16 (RRR: 3.77), HPV18 (RRR: 4.39), and other high-risk HPV (HR-HPV) strains (RRR: 3.62) elevated the risk of CIN2+.
- Interactions between HSIL/ASC-H cytology and HPV16/HPV18 demonstrated the highest risk for CIN2 progression and persistence.
Conclusions
- Patients with prior HSIL or ASC-H cytology require close monitoring for CIN2.
- The presence of HPV16, HPV18, or other HR-HPV strains significantly amplifies the risk of CIN2 progression and persistence.
- Tailored follow-up strategies considering cytology and HPV genotype are essential for managing CIN2 lesions.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...